Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

News Daily News

AHA 提供他汀类药物和心血管药物药物相互作用指导

Michael O'Riordan

October 18, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

更高效、更廉价：成本效益分析称 PCSK9 价格需降低三分之二

Yael L. Maxwell

August 29, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Daily News

Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9

Yael L. Maxwell

August 29, 2016

News Daily News

Tratamiento Antiplaquetario en Pacientes con Stents que Necesitan Cirugía: La Experiencia de Italia Marca el Camino a Seguir

Michael O'Riordan

July 20, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

News Daily News

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

Shelley Wood

January 18, 2016

News Daily News

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

August 04, 2015

News Daily News

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

August 04, 2015

News Daily News

元分析解释了不同DAPT时间长短的影响

Caitlin E. Cox

April 03, 2015

News Daily News

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

L.A. McKeown

February 06, 2014

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

CME

Aspirin for the Interventionalist: More Than Meets the Eye

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Advertisement

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

AHA 提供他汀类药物和心血管药物药物相互作用指导

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

更高效、更廉价：成本效益分析称 PCSK9 价格需降低三分之二

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9

Tratamiento Antiplaquetario en Pacientes con Stents que Necesitan Cirugía: La Experiencia de Italia Marca el Camino a Seguir

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

元分析解释了不同DAPT时间长短的影响

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Aspirin for the Interventionalist: More Than Meets the Eye

Changing Course with Anticoagulation in Secondary Prevention of CAD

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content